Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barni

Showing results (291-300 of 369) with videos related to

Pageof 37
Sort By:
Tumori|December 31, 1989
Ki-67 labeling index in breast cancerS Crispino, A Brenna, D Colombo, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Effects of radical mastectomy on prolactin blood levels in patients with breast cancerS Barni, P Lissoni, F Paolorossi, et al.
La Radiologia Medica|October 1, 1987
[Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area]A Colombo, S Crispino, S Barni, et al.
Tumori|April 30, 1987
Acute effects of various chemotherapeutic combinations on hypophyseal and pineal hormone secretions in cancer patientsS Barni, P Lissoni, G Tancini, et al.
Oncology Reports|May 21, 2011
Preoperative neuroimmunotherapy with subcutaneons low-dose interleukin-2 and melatonin in patients with gastrointestinal tumors - its efficacy in preventing surgery-induced lymphocytopeniaF Brivio, P Lissoni, L Fumagalli, et al.
Tumori|December 31, 1992
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinomaS Barni, P Lissoni, M Cazzaniga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)E Mari, I Floriani, A Tinazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancerC Nisticò, C Garufi, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract CancerR Labianca, G Giaccon, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patientsS Crispino, P Lissoni, A Ardizzoia, et al.
Pageof 37

Showing results (291-300 of 369) with videos related to

Sort By:
Pageof 37
Tumori|December 31, 1989
Ki-67 labeling index in breast cancerS Crispino, A Brenna, D Colombo, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Effects of radical mastectomy on prolactin blood levels in patients with breast cancerS Barni, P Lissoni, F Paolorossi, et al.
La Radiologia Medica|October 1, 1987
[Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area]A Colombo, S Crispino, S Barni, et al.
Tumori|April 30, 1987
Acute effects of various chemotherapeutic combinations on hypophyseal and pineal hormone secretions in cancer patientsS Barni, P Lissoni, G Tancini, et al.
Oncology Reports|May 21, 2011
Preoperative neuroimmunotherapy with subcutaneons low-dose interleukin-2 and melatonin in patients with gastrointestinal tumors - its efficacy in preventing surgery-induced lymphocytopeniaF Brivio, P Lissoni, L Fumagalli, et al.
Tumori|December 31, 1992
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinomaS Barni, P Lissoni, M Cazzaniga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)E Mari, I Floriani, A Tinazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancerC Nisticò, C Garufi, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract CancerR Labianca, G Giaccon, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patientsS Crispino, P Lissoni, A Ardizzoia, et al.
Pageof 37